Cytorex Biosciences Inc., is executing Cancer research agreements with Venezuelan Universities

Cytorex Biosciences Inc., announced today that is executing a research and development agreement with Universidad de Los Andes (Venezuela)
 
 
Spread the Word
Listed Under

Tags:
* Cancer
* Cytoreg
* Cytorex
* Tumors
* Venezuela
* Ula
* Univesidad de Los Andes
* Reserach
* Development

Industry:
* Cancer research

Location:
* Weston - Florida - US

April 29, 2011 - PRLog -- Weston, Florida

April 28, 2011 --


Cytorex Biosciences Inc., a Weston, Florida based biopharmaceutical company , announced today that is executing a research and development agreement through is Venezuela based subsidiary, Cytorex de Venezuela, with Universidad de Los Andes, located in the State of Merida.

“This bicentennial university has all the required facilities and specialized personnel to complete the pre-clinical phase for our lead antitumor compound Cytoreg®. Our agreement includes Toxicology and Pharmacology studies, as well as animal models for efficacy and mechanisms of action of Cytoreg® in a second stage”, indicated William J. Jimenez, Executive Vice-president of the company.
“This agreement started in 2010, and is moving forward in a very positive tone. The expected initial results will be shared with other Research Facilities and Universities. With the inclussion of additional scientists, a high level of added value is expected toward the development of this novel Ionic Therapy which has selective action in several cancer indications”, added Jimenez.
Jimenez concluded indicating that “Cytorex Biosciences, Inc. should be ready to publish the final results of the study, by the end of 2011” .

Cytorex Biosciences, Inc. (Cytorex) is a Weston, Florida preclinical-stage biopharmaceutical company developing therapeutic candidates primarily for the treatment of cancer. Cytoreg®, our patented lead drug candidate, is currently in preclinical testing for cancer, as well as in discovery and preclinical development for indications in diseases of immune origin.

Cytorex’s objective is to market new compounds based on its expertise in formulation of low acidic compositions for use in treatment of disease.

For additional information please contact:
Mr. William J. Jimenez, Vice-President
Cytorex Biosciences, Inc.
4474 Weston Road No. 108, Weston, Fl 33331
E-Mail: wjimenez@cytorex.com
Phone: +1 (954) 573-4006 (USA)
Phone: +58 (414) 614-0226 (Venezuela)
End
Source:Cytorex Biosciences, Inc.
Email:***@gmail.com Email Verified
Phone:954-903-7021
Zip:33331
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share